Ronald  Frost net worth and biography

Ronald Frost Biography and Net Worth

Ronald Frost has been employed by Merit for more than 22 years, serving in multiple positions, including Quality Engineer, Manufacturing Engineer, Custom Kits Manager, Customer Service Manager, Production Planning and Warehouse Manager, General Manager of Merit’s Richmond, VA, operations, and Vice President of Technology Transfer.

At the time of his appointment as Chief Operating Officer, Frost was serving as Merit’s Vice President of Materials and Operations, a position he has held since December 2007.

What is Ronald Frost's net worth?

The estimated net worth of Ronald Frost is at least $1.15 million as of August 10th, 2022. Mr. Frost owns 15,144 shares of Merit Medical Systems stock worth more than $1,147,158 as of March 29th. This net worth approximation does not reflect any other investments that Mr. Frost may own. Learn More about Ronald Frost's net worth.

How do I contact Ronald Frost?

The corporate mailing address for Mr. Frost and other Merit Medical Systems executives is 1600 WEST MERIT PARK WAY, SOUTH JORDAN UT, 84095. Merit Medical Systems can also be reached via phone at (801) 253-1600 and via email at [email protected]. Learn More on Ronald Frost's contact information.

Has Ronald Frost been buying or selling shares of Merit Medical Systems?

Ronald Frost has not been actively trading shares of Merit Medical Systems during the past quarter. Most recently, Ronald Frost sold 20,000 shares of the business's stock in a transaction on Wednesday, August 10th. The shares were sold at an average price of $62.10, for a transaction totalling $1,242,000.00. Following the completion of the sale, the chief operating officer now directly owns 15,144 shares of the company's stock, valued at $940,442.40. Learn More on Ronald Frost's trading history.

Who are Merit Medical Systems' active insiders?

Merit Medical Systems' insider roster includes A. Anderson (Director), Jill Anderson (Director), David Floyd (Director), Ronald Frost (COO), Fred Lampropoulos (CEO), Brian Lloyd (Insider), F. Millner (Director), Raul Parra, Jr. (CFO), Neil Peterson (COO), Michel Voigt (Insider), Lynne Ward (Director), and Joseph Wright (Insider). Learn More on Merit Medical Systems' active insiders.

Are insiders buying or selling shares of Merit Medical Systems?

In the last twelve months, insiders at the medical instruments supplier sold shares 6 times. They sold a total of 99,817 shares worth more than $7,434,244.71. The most recent insider tranaction occured on March, 12th when CFO Raul Jr. Parra sold 6,480 shares worth more than $479,196.00. Insiders at Merit Medical Systems own 3.7% of the company. Learn More about insider trades at Merit Medical Systems.

Information on this page was last updated on 3/12/2024.

Ronald Frost Insider Trading History at Merit Medical Systems

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/10/2022Sell20,000$62.10$1,242,000.0015,144View SEC Filing Icon  
6/15/2021Sell11,887$61.82$734,854.3422,343View SEC Filing Icon  
3/16/2021Sell5,000$60.60$303,000.002,343View SEC Filing Icon  
3/12/2021Sell25,000$59.58$1,489,500.0032,343View SEC Filing Icon  
7/30/2019Buy5,000$40.00$200,000.005,000View SEC Filing Icon  
11/16/2018Sell4,743$61.30$290,745.904,743View SEC Filing Icon  
11/7/2018Sell5,257$61.31$322,306.675,257View SEC Filing Icon  
3/16/2015Sell11,250$19.50$219,375.00View SEC Filing Icon  
6/19/2014Sell5,000$14.25$71,250.00View SEC Filing Icon  
6/3/2014Sell2,325$14.07$32,712.75View SEC Filing Icon  
See Full Table

Ronald Frost Buying and Selling Activity at Merit Medical Systems

This chart shows Ronald Frost's buying and selling at Merit Medical Systems by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Merit Medical Systems Company Overview

Merit Medical Systems logo
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.
Read More

Today's Range

Now: $75.75
Low: $75.13
High: $76.34

50 Day Range

MA: $77.19
Low: $71.86
High: $81.25

2 Week Range

Now: $75.75
Low: $62.58
High: $85.62

Volume

314,270 shs

Average Volume

542,383 shs

Market Capitalization

$4.39 billion

P/E Ratio

46.76

Dividend Yield

N/A

Beta

0.9